Show simple item record

dc.contributor.authorKorban, Schuyler S.
dc.date.accessioned2017-06-07T17:49:25Z
dc.date.available2017-06-07T17:49:25Z
dc.date.issued2005
dc.identifier.urihttps://hdl.handle.net/1813/51001
dc.description.abstractIn recent years, there has been a move towards developing subunit vaccines whereby linear immunogenic epitopes of a pathogen elicit production of antibodies. A novel approach for developing subunit vaccines has emerged as a result of genetic engineering technology: use of plants as vehicles for developing new products. As the technology to produce vaccines in plants goes through the regulatory pathway and demonstrates its economic feasibility, it may also overcome public-perception concerns that have dogged agricultural biotechnology in the past decade.
dc.language.isoen_US
dc.publisherNABC
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAgricultural biotechnology
dc.subjectenvironment, human health
dc.subjectGMO, genetic engineering, pharming
dc.subjectplant based vaccines
dc.subjectmedicinals
dc.subjectregulation
dc.subjectliability, patents
dc.subjectstewardship
dc.titleOpportunities and challenges for plant-based vaccines
dc.typebook chapter


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International

Statistics